Synthetic, irreversible MAO-A inhibitors (clorgyline) showed critical side effects, and reversible MAO-A inhibitors (moclobemide, brofaromine, toloxatone) are clinically applied for the treatment of anxiety and depression. The gene discussed is MAOA; the disease is major depressive disorder.